Afuco™ Anti-Ovr110 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-Ovr110 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies and antigen binding fragments directed against Ovr110 which is expressed by head and neck, ovarian, endometrial, kidney, pancreatic, lung or breast cancer are provided, are used for alleviating or treating an Ovr110-expressing cancer in a mammal.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-758CL |
| Pricing | Inquiry |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |
| Host | Human |
| Target | Ovr110 |